The Case for GNMT as a Biomarker and a Therapeutic Target in Pancreatic Cancer

The high mortality rate for pancreatic cancer (PC) is due to the lack of specific symptoms at early tumor stages and a high biological aggressiveness. Reliable biomarkers and new therapeutic targets would help to improve outlook in PC. In this study, we analyzed the expression of GNMT in a panel of...

Descripción completa

Detalles Bibliográficos
Autores principales: Heinzman, Zachary, Schmidt, Connor, Sliwinski, Marek K., Goonesekere, Nalin C. W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998508/
https://www.ncbi.nlm.nih.gov/pubmed/33802396
http://dx.doi.org/10.3390/ph14030209

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998508/
https://www.ncbi.nlm.nih.gov/pubmed/33802396
http://dx.doi.org/10.3390/ph14030209

Ejemplares similares